StockData
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) stock

MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/304% above fair value
$398.08−23.91 (-5.67%)

Close on Nov 18, 2026Market cap $9.20BP/E –Yield –

Madrigal Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Madrigal Pharmaceuticals's pe ratio was 2.0× on Feb 28, 2011.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2011Feb 28, 20112.0×−0.2
2010Dec 31, 20102.1×–

More Madrigal Pharmaceuticals figures

See a number that looks wrong?